Coxsackievirus B5 protein (30-1334)
Purified native Coxsackievirus B5 protein (Faulkener Strain)
Overview
Overview
| Synonyms | Coxsackie B protein, Coxsackie B5 protein, Coxsackievirus Faulkener protein, B5 protein, Coxsackievirus protein, Coxsackievirus antigen, Coxsackievirus, Faulkener strain Coxsackievirus |
|---|---|
| Species | Viral |
| Protein Type | Native |
Specifications
| Source | Vero cells; Faulkener strain |
|---|---|
| Grade & Purity | Partially pure |
| Method of Purification | Coxsackievirus B5 protein was purified by ultracentrifugation |
| Form & Buffer | Suppliedin partially purified liquid cell culture media with no preservative. Cell debris was removed by clarification of infected cells. |
Storage & Safety
| Storage | Store at -20 deg c to -80 deg C, avoid multiple freeze/thaw cycles |
|---|
General Information
| Biological Significance | Group B coxsackieviruses tend to infect the heart, pleura, pancreas, and liver, causing pleurodynia, myocarditis, pericarditis, and hepatitis (inflammation of the liver not related to the hepatotropic viruses). Coxsackie B infection of the heart can lead to pericardial effusion. Muffled heart sounds and pulsus paradoxus are signs of this. The development of insulin-dependent diabetes (IDDM) has recently been associated with recent enteroviral infection, particularly coxsackievirus B pancreatitis. This relationship is currently being studied further. Sjogren's syndrome is also being studied in connection with coxsackievirus, as of January 2010. |
|---|
Reviews
You need to be logged in to write a review. Please login here
Sorry there are currently no reviews for this product